Conmed Corp. Company Profile (NASDAQ:CNMD)

About Conmed Corp.

Conmed Corp. logoCONMED Corporation is a medical technology company. The Company is engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment. Its products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. Its product lines consist of orthopedic surgery, general surgery and surgical visualization. Its orthopedic surgery product lines include sports medicine, powered surgical instruments, and sports biologics and tissue. Its general surgery product line offers a range of products in the areas of advanced surgical, endoscopic technologies and critical care. Its surgical visualization product line offers imaging systems for use in minimally invasive orthopedic and general surgery procedures. Its products are distributed domestically directly to over 6,000 hospitals and other healthcare institutions, as well as through medical specialty distributors.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: CNMD
  • CUSIP: 20741010
Key Metrics:
  • Previous Close: $39.81
  • 50 Day Moving Average: $39.99
  • 200 Day Moving Average: $42.11
  • 52-Week Range: $35.51 - $50.16
  • Trailing P/E Ratio: 63.36
  • Foreward P/E Ratio: 19.32
  • P/E Growth: 2.47
  • Market Cap: $1.09B
  • Outstanding Shares: 27,817,000
  • Beta: 0.9
  • Net Margins: 2.36%
  • Return on Equity: 8.11%
  • Return on Assets: 3.86%
  • Debt-to-Equity Ratio: 0.88%
  • Current Ratio: 3.49%
  • Quick Ratio: 1.80%
Additional Links:
Companies Related to Conmed Corp.:

Analyst Ratings

Consensus Ratings for Conmed Corp. (NASDAQ:CNMD) (?)
Ratings Breakdown: 1 Hold Rating, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $48.00 (22.39% upside)

Analysts' Ratings History for Conmed Corp. (NASDAQ:CNMD)
DateFirmActionRatingPrice TargetDetails
7/28/2016Leerink SwannDowngradeOutperform -> Market Perform$56.00 -> $47.00View Rating Details
4/28/2016Needham & Company LLCBoost Price TargetBuy$48.00 -> $49.00View Rating Details
11/17/2015Deutsche Bank AGReiterated RatingBuyView Rating Details
10/22/2015Northland SecuritiesLower Price TargetMarket Perform$58.00 -> $44.00View Rating Details
10/12/2015Ladenburg ThalmannUpgradeNeutral -> Buy$55.00View Rating Details
8/27/2015Piper Jaffray Cos.Reiterated RatingNeutral$51.00View Rating Details
5/15/2015Northland Capital PartnersInitiated CoverageOutperform$65.00View Rating Details
3/16/2015KeyCorpInitiated CoverageSector WeightView Rating Details
1/28/2015Summer StreetBoost Price TargetBuy$46.00 -> $56.00View Rating Details
(Data available from 10/26/2014 forward)


Earnings History for Conmed Corp. (NASDAQ:CNMD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/27/2016Q316$0.40$180.13 millionListenView Earnings Details
7/27/2016Q216$0.46$0.47$191.48 million$193.40 millionViewListenView Earnings Details
4/27/2016Q116$0.41$0.42$180.15 million$181.20 millionViewListenView Earnings Details
1/27/2016Q415$0.51$0.52$191.03 million$191.00 millionViewListenView Earnings Details
10/21/2015Q315$0.43$0.38$173.96 million$169.20 millionViewListenView Earnings Details
7/21/2015Q215$0.44$0.36$182.40 million$181.00 millionViewListenView Earnings Details
4/22/2015Q115$0.43$0.42$176.16 million$177.90 millionViewListenView Earnings Details
1/27/2015Q414$0.54$0.53$196.00 million$195.00 millionViewListenView Earnings Details
10/23/2014Q314$0.39$0.44$173.30 million$175.00 millionViewListenView Earnings Details
7/23/2014Q214$0.47$0.47$190.62 million$188.20 millionViewListenView Earnings Details
4/24/2014Q1$0.47$0.49$191.95 million$181.90 millionViewListenView Earnings Details
2/13/2014Q413$0.49$0.53$197.24 million$203.40 millionViewListenView Earnings Details
10/24/2013Q313$0.40$0.40$186.20 million$179.30 millionViewListenView Earnings Details
7/24/2013Q2 2013$0.44$0.43$193.55 million$193.00 millionViewListenView Earnings Details
4/25/2013Q1 2013$0.45$0.45$196.79 million$187.00 millionViewListenView Earnings Details
2/14/2013Q4 2012$0.50$0.52$200.12 million$201.20 millionViewListenView Earnings Details
10/25/2012$0.40$0.43ViewN/AView Earnings Details
7/26/2012$0.45$0.43ViewN/AView Earnings Details
4/26/2012$0.44$0.43ViewN/AView Earnings Details
2/15/2012$0.39$0.46ViewN/AView Earnings Details
10/27/2011$0.31$0.33ViewN/AView Earnings Details
7/28/2011$0.35$0.35ViewN/AView Earnings Details
4/28/2011$0.31$0.37ViewN/AView Earnings Details
2/3/2011$0.36$0.36ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Conmed Corp. (NASDAQ:CNMD)
Current Year EPS Consensus Estimate: $1.87 EPS
Next Year EPS Consensus Estimate: $2.03 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.37$0.52$0.44
Q2 20164$0.44$0.49$0.46
Q3 20162$0.40$0.41$0.41
Q4 20162$0.59$0.60$0.60
(Data provided by Zacks Investment Research)


Current Dividend Information for Conmed Corp. (NASDAQ:CNMD)
Annual Dividend:$0.80
Dividend Yield:2.04%
Payout Ratio:129.03% (Based on Trailing 12 Months of Earnings)
42.78% (Based on Current Year Consensus EPS Estimate)
39.41% (Based on Next Year Consensus EPS Estimate)

Dividend History for Conmed Corp. (NASDAQ:CNMD)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Conmed Corp. (NASDAQ:CNMD)
Insider Ownership Percentage: 1.91%
Institutional Ownership Percentage: 98.80%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/3/2016Charles FarkasDirectorBuy336$40.04$13,453.44View SEC Filing  
7/1/2016Charles FarkasDirectorBuy282$47.87$13,499.34View SEC Filing  
6/3/2016Luke A PomilioCFOSell4,400$41.56$182,864.00View SEC Filing  
4/1/2016Charles FarkasDirectorBuy338$42.04$14,209.52View SEC Filing  
3/4/2016Mark D SnyderEVPSell2,940$41.32$121,480.80View SEC Filing  
3/2/2016John L WorkmanDirectorBuy2,500$39.85$99,625.00View SEC Filing  
2/19/2016Jerome J LandeDirectorSell1,630,800$38.28$62,427,024.00View SEC Filing  
1/4/2016Charles FarkasDirectorBuy332$42.18$14,003.76View SEC Filing  
12/11/2015David M BronsonDirectorBuy1,500$41.01$61,515.00View SEC Filing  
6/12/2015Jo Ann GoldenDirectorSell1,000$56.03$56,030.00View SEC Filing  
5/29/2015Stephen MandiaDirectorSell14,000$55.62$778,680.00View SEC Filing  
5/6/2015Pat BeyerInsiderBuy5,000$53.36$266,800.00View SEC Filing  
4/30/2015Stephen MandiaDirectorSell3,899$49.97$194,833.03View SEC Filing  
12/12/2014Stephen MandiaDirectorSell4,500$43.23$194,535.00View SEC Filing  
12/1/2014Dirk KuyperDirectorSell1,000$42.85$42,850.00View SEC Filing  
11/19/2014Joseph G DarlingEVPSell4,270$42.00$179,340.00View SEC Filing  
10/29/2014Robert D Shallish JrCFOSell10,410$41.67$433,784.70View SEC Filing  
9/4/2014William AbrahamEVPSell16,062$39.91$641,034.42View SEC Filing  
8/26/2014William AbrahamEVPSell7,423$38.36$284,746.28View SEC Filing  
8/21/2014William AbrahamEVPSell15,986$37.71$602,832.06View SEC Filing  
8/19/2014William AbrahamEVPSell5,312$37.75$200,528.00View SEC Filing  
7/31/2014Curt R HartmanCEOBuy10,000$39.25$392,500.00View SEC Filing  
7/30/2014Bruce DanielsDirectorSell1,600$39.31$62,896.00View SEC Filing  
7/30/2014Joseph J CorasantiCEOSell109,035$39.25$4,279,623.75View SEC Filing  
10/29/2013Joseph J CorasantiCEOSell80,148$36.47$2,922,997.56View SEC Filing  
10/28/2013Bruce DanielsDirectorSell4,500$36.43$163,935.00View SEC Filing  
9/13/2013Joseph CorasantiCEOSell44,852$33.04$1,481,910.08View SEC Filing  
9/11/2013William AbrahamSVPSell7,423$33.48$248,522.04View SEC Filing  
8/15/2013Dirk KuyperDirectorBuy1,000$31.63$31,630.00View SEC Filing  
6/7/2013Daniel JonasVPSell2,000$32.42$64,840.00View SEC Filing  
6/4/2013Heather L CohenVPSell1,200$32.59$39,108.00View SEC Filing  
5/31/2013Luke A PomilioVPSell2,556$33.19$84,833.64View SEC Filing  
5/29/2013Heather L CohenVPSell4,514$34.31$154,875.34View SEC Filing  
5/28/2013Robert D Shallish JrCFOSell10,000$34.35$343,500.00View SEC Filing  
2/15/2013Stuart J SchwartzDirectorSell1,000$30.32$30,320.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Conmed Corp. (NASDAQ:CNMD)
DateHeadline logoCONMED Corp. : CNMD-US: Dividend Analysis : September 15th, 2016 (record date) : By the numbers : October 21, 2016 (NASDAQ:CNMD) - October 21 at 4:21 PM logoCONMED Corp. breached its 50 day moving average in a Bullish Manner : CNMD-US : October 19, 2016 (NASDAQ:CNMD) - October 19 at 9:14 AM logoCONMED Corporation (NASDAQ:CNMD) Deferred Tax Assets At $14.15 (NASDAQ:CNMD) - October 16 at 4:14 PM logoCONMED Corporation to Announce Third Quarter 2016 Financial Results on October 27, 2016 (NASDAQ:CNMD) - October 10 at 4:11 PM logoCan CONMED Corporation (NASDAQ:CNMD) Outdo Analysts EPS Target Of $0.41? (NASDAQ:CNMD) - October 8 at 4:13 PM logoCONMED Corporation (NASDAQ:CNMD) Mean Rating At $2.17 (NASDAQ:CNMD) - October 8 at 4:13 PM logoCONMED Corp. breached its 50 day moving average in a Bullish Manner : CNMD-US : October 6, 2016 (NASDAQ:CNMD) - October 6 at 9:54 AM logoETF’s with exposure to CONMED Corp. : October 6, 2016 (NASDAQ:CNMD) - October 6 at 9:54 AM
News IconBroker Roundup For CONMED Corporation (NASDAQ:CNMD) (NASDAQ:CNMD) - October 3 at 4:12 PM
News IconCONMED Corporation (NASDAQ:CNMD) Updated Broker Price Targets (NASDAQ:CNMD) - September 29 at 4:11 PM logoCONMED Corporation (NASDAQ:CNMD)’s Accounts Payable Is $32.033 (NASDAQ:CNMD) - September 25 at 3:55 PM logoA Price Target Of $48.4 Is Set By Research Analysts For CONMED Corporation (NASDAQ:CNMD) (NASDAQ:CNMD) - September 11 at 4:07 PM logoCan CONMED Corporation (NASDAQ:CNMD) Meet Analysts Expectations? (NASDAQ:CNMD) - September 11 at 4:07 PM logoETF’s with exposure to CONMED Corp. : September 9, 2016 (NASDAQ:CNMD) - September 9 at 4:09 PM logoCONMED Corporation to Present at the Morgan Stanley Global Healthcare Conference (NASDAQ:CNMD) - August 31 at 4:16 PM
News IconConMed Announces Quarterly Cash Dividend (NASDAQ:CNMD) - August 28 at 8:57 AM
News IconConMed to pay quarterly dividend of 20 cents in October (NASDAQ:CNMD) - August 26 at 4:16 PM logoCONMED CORP Files SEC form 8-K, Other Events (NASDAQ:CNMD) - August 26 at 4:16 PM logoCONMED Corporation (NASDAQ:CNMD) Reports Accounts Payable Of $32.033 (NASDAQ:CNMD) - August 20 at 4:21 PM logoETF’s with exposure to CONMED Corp. : August 8, 2016 (NASDAQ:CNMD) - August 8 at 4:25 PM logoCONMED Corp. :CNMD-US: Earnings Analysis: Q2, 2016 By the Numbers : August 4, 2016 (NASDAQ:CNMD) - August 4 at 11:15 AM logoCONMED Corporation (CNMD) is Trading Lower on Unusual Volume for July 28 (NASDAQ:CNMD) - July 30 at 4:01 PM logoOversold Conditions For Conmed (CNMD) (NASDAQ:CNMD) - July 30 at 4:01 PM logoCONMED Corp. breached its 50 day moving average in a Bearish Manner : CNMD-US : July 29, 2016 (NASDAQ:CNMD) - July 29 at 8:38 AM logoConmed Corp. (CNMD) Is Sinking After Outlook Disappoints (NASDAQ:CNMD) - July 28 at 12:17 PM logoConmed Corp. Earnings Rise 10% In Q2 (NASDAQ:CNMD) - July 27 at 10:01 PM logoConmed beats Street 2Q forecasts (NASDAQ:CNMD) - July 27 at 5:23 PM logoQ2 2016 Conmed Corp Earnings Release - After Market Close (NASDAQ:CNMD) - July 27 at 7:07 AM logoDental Stock Earnings Queued Up for Jul 27: MCK, LH & More (NASDAQ:CNMD) - July 26 at 8:55 AM logoCONMED Corporation to Announce Second Quarter 2016 Financial Results on July 27, 2016 (NASDAQ:CNMD) - July 7 at 4:01 PM
News IconDirector of CONMED Corporation (NASDAQ:CNMD), Farkas Charles, buys 282 shares worth $13,499 (NASDAQ:CNMD) - July 6 at 9:03 AM logoCR Bard: Expansion Plans on Track, Product Pipeline Strong (NASDAQ:CNMD) - July 5 at 9:04 AM logoCONMED Corporation (CNMD) is Trading Higher on Unusual Volume for June 20 (NASDAQ:CNMD) - June 22 at 4:30 PM logoDENTSPLY Sirona (XRAY): Q1 Strong, Expansion on Track (NASDAQ:CNMD) - June 20 at 10:38 AM logoCONMED Corporation (CNMD) is Trading Lower on Unusual Volume for June 15 (NASDAQ:CNMD) - June 17 at 12:11 PM logoEx-Dividend Reminder: UGI, Thermo Fisher Scientific and Conmed (NASDAQ:CNMD) - June 9 at 4:17 PM logoCONMED Corp. – Value Analysis (NASDAQ:CNMD) : June 6, 2016 (NASDAQ:CNMD) - June 6 at 5:06 PM logoCONMED Corp. breached its 50 day moving average in a Bullish Manner : CNMD-US : June 3, 2016 (NASDAQ:CNMD) - June 3 at 8:05 AM
News IconEarnings Review and Stock Rundown for CONMED Corporation (NASDAQ:CNMD) - Wall Street Hints and News (NASDAQ:CNMD) - May 28 at 2:33 PM logoCONMED CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events (NASDAQ:CNMD) - May 26 at 4:37 PM logoETF’s with exposure to CONMED Corp. : May 24, 2016 (NASDAQ:CNMD) - May 24 at 2:59 PM logoCONMED CORP Files SEC form 10-Q, Quarterly Report (NASDAQ:CNMD) - May 2 at 4:49 PM logoCONMED Corp. :CNMD-US: Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:CNMD) - April 29 at 10:09 AM logoCONMED (CNMD) Q1 Earnings Miss, Sales Beat; Stock Down (NASDAQ:CNMD) - April 29 at 8:54 AM logoEdited Transcript of CNMD earnings conference call or presentation 27-Apr-16 8:30pm GMT (NASDAQ:CNMD) - April 28 at 2:53 AM logoConmed reports 1Q loss (NASDAQ:CNMD) - April 27 at 5:46 PM logoCONMED Corporation Announces First Quarter 2016 Financial Results (NASDAQ:CNMD) - April 27 at 4:27 PM
News IconScopia Capital Boosts Stake in CONMED, Plus 2 Other Ongoing Activist Battles (NASDAQ:CNMD) - March 31 at 1:55 PM
News IconCONMED Corp (CNMD): Scopia Capital Isn’t Done Buying Shares (NASDAQ:CNMD) - March 10 at 1:01 AM logoCONMED Corporation Adds Health Care Executive Martha Goldberg Aronson to its Board of Directors (NASDAQ:CNMD) - February 23 at 8:00 AM


Conmed Corp. (NASDAQ:CNMD) Chart for Wednesday, October, 26, 2016

Last Updated on 10/26/2016 by Staff